Welcome to the Medical Diagnostic center Science Labs
What is Clarigo™ NIPT offered by Science Labs?
The Clarigo™ NIPT test, that has been developed in Europe and is implemented in Science Labs Diagnostic center, analyzes circulating cell free fetal DNA that is released to the maternal blood system from the placenta.
Clarigo can be performed at as early as 8 weeks gestation. With a simple maternal blood draw and no risk either for the mother or for the fetus, it analyzes the 3 most common chromosomal aneuploidies: Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), Patau syndrome (trisomy 13).
These rare chromosomal aneuploidies of chromosomes 21/18/13, with Down syndrome being the most common – with a detection rate approximately 1 out of 450 pregnancies – are the most likely genetic defects threatening a pregnancy.
Where is the test implemented?
By applying the breakthrough technology of targeted Massively Parallel Sequencing of cf DNA on the Illumina Next Generation Sequencing System, NextSeq 500, the fetal DNA can be analyzed by Deep Sequencing of million independent sequences in order a possible chromosomal aneuploidy to be detected in chromosomes 21, 18 and 13.
Why Science Labs?
6 steps that must be followed for the Clarigo™ NIPT test
Main features
Highly accurate trisomy assessment
• Established sensitivity and specificity for trisomies 21, 18 and 13.
Reliability
• Fetal fraction is reported for both male and female fetus samples to exclude the false negative results.
• CE/IVD marking obtained after a large multi-center study comprising approximately 1,900 samples from 3 independent clinical laboratories.
Affordable
• Clarigo™ NIPT test is affordable and therefore available to more pregnant women. The lower price is achieved by using state of the art technology (full automation).
Main features
Speed
• The Medical Diagnostic Center, Science Labs can report the results within 3 – 5 working days after sample receipt.
Localization (Greece)
• Unlike all other NIPT tests, for which the sample travels even overseas, the Clarigo™ NIPT is implemented completely in Science Labs, from Greek scientists, after successfully completing a relevant certification process from the manufacturing company.
Simplicity
• Clarigo™ NIPT test requires only one simple and safe maternal blood draw.
• Clear results
Safety
• Non invasive procedure, safe for the fetus and the mother.

